.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India recently launched a groundbreaking global clinical study evaluating Ayurveda in TB treatment as a supportive therapy. This initiative aims to scientifically validate traditional medicine alongside modern regimens. Consequently, researchers will monitor how these combined therapies influence patient recovery and long-term health outcomes. Furthermore, the collaboration between the Ministry of Ayush and the Department of Biotechnology marks a significant milestone in integrative healthcare.
The study involves 1,250 newly diagnosed tuberculosis patients across eight major institutions. Participants will receive standard anti-tuberculosis treatment alongside a defined Ayurveda regimen. Additionally, investigators will track changes in body weight and nutritional status. They will also assess disease progression and the overall quality of life for participants. Safety and tolerability remain primary endpoints throughout this trial.
Many patients experience persistent weakness even after completing successful antibiotic courses. Therefore, Union Minister Jitendra Singh emphasized the need for host-directed therapies. India's rich heritage of Ayurveda offers unique opportunities to boost immunity and enhance nutrition. This holistic approach might bridge the gap in current care protocols. Moreover, it aligns with India's goal of eliminating TB by 2025.
India currently accounts for nearly 25 percent of the global TB burden. However, the nation saw a 21 percent reduction in incidence between 2015 and 2024. This drop reflects the success of early diagnosis and universal drug testing. Thus, the government continues to strengthen patient-centric care under the National TB Elimination Programme. This clinical trial supports these ongoing efforts effectively.
Q1: What is the primary goal of this clinical study?
The study aims to evaluate Ayurveda as an adjunct therapy to improve nutritional outcomes, immunity, and quality of life in TB patients.
Q2: How many patients are participating in the trial?
The trial will enrol 1,250 newly diagnosed TB patients across eight different institutions in India.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India starts a clinical study on 1,250 patients to evaluate Ayurveda as an adjunct to TB treatment for better recovery, nutrition, and overall quality of li...
6 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
